Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Remote Physical Activity Program Via the PACE Tool to Counter the Physical Impairments, Accentuated by the Pandemic, in the Population Suffering from Type 1 Myotonic Dystrophy

NCT05072288 is registered in ClinicalTrials.gov with Université du Québec à Chicoutimi as lead sponsor.

NCT NCT05072288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05072288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Remote Physical Activity Program Via the PACE Tool to Counter the Physical Impairments, Accentuated by the Pandemic, in the Population Suffering from Type 1 Myotonic Dystrophy
Lead sponsor
Université du Québec à Chicoutimi
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 11, 2021
Completion date
December 1, 2026
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

myotonic dystrophy type 1 (dm1)